Home Contact Center Add this

Pipeline

 

NomDescriptionStage
Debio 1450, ABSSSI , FabI inhibitor 4 FT / QIDP
Debio 1143, Head & Neck cancer , SMAC mimetic 3.5
Debio 1143, Ovarian cancer , SMAC mimetic 3.25 ODD
Debio 1450, Bone & joint infections , FabI inhibitor 3 FT / QIDP
Debio 1347 Oncology, FGFR 1,2,3 inhibitor 2.5
Debio 1143, NSCLC* , SMAC mimetic 2
Debio 1562 non-Hodgkin lymphoma, anti-CD37 ADC 3.25
Debio 025/Musc.Dystrophy , Cyclophilin inhibitor 1.75
Debio 1453 N.gonorrhoeae, H. pylori, Fabl inhibitor 0.25
Debio 1454 Enteric Species, FabI inhibitor 0.25

ODD

Orphan Drug Designation

FT

Fast Track

QIDP

Qualified Infectious Disease Product



*In combination with avelumab

 

Debiopharm Group's projects cover all molecule type proteins, peptides, small molecules

 

NomDescriptionStage
Septicyte TriageInfectious Diseases, DxTechnology1.5
Debio 1561Infectious Diseases, DxTechnology0.75